Tuesday, March 31, 2015
BioCryst Recieves $12M to Develop Ebola Drug
Durham-based BioCryst Pharmaceuticals is receiving $12 million from the federal government to fund further development of a possible drug to treat the deadly Ebola virus.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment